Standard titration protocol from clinical trials The Phase 2 NEJM trial used the following escalation schedule for the 12 mg dose group: Weeks 1 through 4: 2 mg once weekly (subcutaneous) Weeks 5 through 8: 4 mg once weekly Weeks 9 through 12: 8 mg once weekly Week 13 and beyond: 12 mg once weekly (maintenance dose) For the 8 mg target dose, the schedule was: Weeks 1 through 4: 2 mg once weekly Weeks 5 through 8: 4 mg once weekly Week 9 and beyond: 8 mg once weekly (maintenance dose) These titration schedules are not suggestions
Novo Nordisk will continue pursuing legal action to protect patients from the risks posed by unapproved knockoff drugs and foreign illicit active pharmaceutical ingredients (API)
Despite this relative decline, NAEs persisted as a substantial AE subset, maintaining notable absolute reporting frequencies during the final three observation years (20212024) (Fig
Someone who's always grown up living in a larger body probably had bullying when they were younger, and psychologically maybe didn't have as much social interaction because of shame or embarrassment, and so on
Full side-by-side
It works by increasing insulin secretion, reducing glucagon, slowing gastric emptying, and reducing appetite